Next Generation
Sequencing
Technology

GeneKor’ s Scientific Team has over 15 years of experience in cancer genetics and has performed thousands of hereditary cancer tests. The HerediGENE test is designed in order to have a very high sensitivity and specificity. All the findings from the analysis of each patient’s sample are classified by using the most reliable and updated databases.

LEARN MORE

Hereditary Cancer Risk Assessment: Is it Important?

Knowledge of the risk for hereditary cancer provides physicians with several different options for the management of a patient:

  • International management guidelines are available for a number of syndromes associated with hereditary cancer predisposition.
  • Dramatic reduction in the occurrence of primary tumors can be achieved.
  • International guidelines recognize the value of the use of hereditary gene panels.
  • Novel targeted therapy drugs have been and are being developed. They are designed to target the specific mutated protein, individualizing the treatment of the patients.
LEARN MORE

Individualized Management

Risk Reduction

It's a family issue

52, Spaton Ave.
153 44 Gerakas-Greece
Tel. +30 210 6032138
Fax +30 210 6032148
info@genekor.com

© 2019 Genekor. All rights reserved. Terms of Use